A single dose of erythropoietin in ST-elevation myocardial infarction.
about
Ischaemic postconditioning: cardiac protection after the eventCardioprotection during cardiac surgeryStrategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial InfarctionDid clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease.Novel adjunctive treatments of myocardial infarction.Erythropoietin action in stress response, tissue maintenance and metabolism.The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI.The effect of erythropoietin on normal and neoplastic cells.Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.High-dose erythropoietin in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized controlled trials.Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.Erythropoietin in the intensive care unit: beyond treatment of anemia.Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction.Contemporary perspective on endogenous myocardial regeneration.Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapyEffects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.Myocardial ischemia-reperfusion injury: a neglected therapeutic target.Conditioning the heart to prevent myocardial reperfusion injury during PPCIHuman erythropoietin gene delivery for cardiac remodeling of myocardial infarction in ratsSerum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndromeImpact of erythropoietin on intensive care unit patientsMigration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarctionProtein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.Baseline Hemoglobin Levels Associated with One-Year Mortality in ST-Segment Elevation Myocardial Infarction PatientsNew strategies for the management of no-reflow after primary percutaneous coronary intervention.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.Organ-protective and immunomodulatory effects of erythropoietin--an update on recent clinical trials.Erythropoietin: a future therapy for failing hearts?Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials.Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis.Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
P2860
Q26853129-0DE9A0C8-CBFF-40A9-B0D2-7A05180F5720Q26866366-62DD3889-022A-469C-B701-96E4047F1CCAQ28077893-665FE095-E678-443F-8BB1-76296D34EFD2Q31056941-CF78A28B-B649-4120-8B4A-76F9D3D3EA6DQ33792006-87575102-1EF1-41CB-8C15-E12080347596Q33812924-D2160D49-C1EB-469D-ABE7-5B20BE802D29Q33907747-4111BF0D-699A-483B-94B7-8671F0000A8BQ34193545-F911BBDB-BEFE-4132-9C37-0B5EF57A969EQ34291437-118F8166-7972-4CCF-8F68-529211FD722DQ34479931-5C9C03E2-51F1-4E21-AF64-BC6F4E32EAA3Q35008662-2E14EA4A-6018-45EA-8187-C4135BA695C0Q35217404-01CA9451-704F-45E1-9FA0-6C080BA45C38Q35569452-0F7EBE4C-CF3A-45AB-8DC3-4974AF7232A2Q35574024-06A841C0-8692-4FA2-8FE6-AA87CAAC732DQ35705440-177280B8-A3C8-4A65-B429-8C62C065B811Q35774278-5906859C-76F6-4314-89D1-076E9FE0DF20Q36232271-C4D2DE3F-0CC1-48CF-BA1C-394A4B026F72Q36288965-B0A92A10-30F4-4A3C-BF7B-03E915010AD9Q36364317-836DCECD-A4D4-432D-B308-3895916157A9Q36497176-2CD6AB19-B18D-4F5C-BBE5-0786ECC3F015Q37140973-DFF6BA29-39B0-4CBB-A80D-F2AA83A5C769Q37158904-352F9AD5-DE61-4361-A48F-D4C1C5EF1A9FQ37291818-2CBE3CEB-5BC2-4254-81B1-853504C1D57CQ37293172-E64DD23B-67F8-489A-B981-8FFE4CF42BD2Q37295247-9AE89AA6-D75E-49BE-A139-B1A351C89462Q37405644-9D08B4A0-C678-4875-9002-C9FC78EF74A4Q37448627-A6D72285-B4F7-45F8-9601-B36A0C4EFCF3Q37880139-F0D9A488-78E7-4F44-B092-37DEC837E6A1Q37883005-33608EEA-44C4-425F-BC3E-1C7D0282034FQ37885482-F78BCE86-187E-4BEE-8573-FF2A4A7498A6Q37946499-A2FBB60C-F59B-4A08-A532-1C3A2FCA47AEQ37952603-5AFAFD21-7BF1-4E54-A472-FB2C6F1CBC22Q37956569-6F21F9FE-0BCB-4D12-BA29-246E69C4A4CBQ38010782-42EC594D-480E-49A3-A1BA-5BD4487917A9Q38025012-4B8A43FD-3851-49A3-9ECE-1F0A8989721CQ38037185-D07B821B-AFB8-4A6E-A651-51ACEE54CBA5Q38075417-E580FA51-4F86-4E3F-AC4C-0C7BC7B26E01Q38108537-B511AAEB-5E27-4DC7-A351-157D98FA4CF9Q38127584-6C9989B2-D5AA-412B-9516-47BA3F87938BQ38137849-6F7914E7-AD7E-4F82-99C0-45333301CFFD
P2860
A single dose of erythropoietin in ST-elevation myocardial infarction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A single dose of erythropoietin in ST-elevation myocardial infarction.
@en
A single dose of erythropoietin in ST-elevation myocardial infarction.
@nl
type
label
A single dose of erythropoietin in ST-elevation myocardial infarction.
@en
A single dose of erythropoietin in ST-elevation myocardial infarction.
@nl
prefLabel
A single dose of erythropoietin in ST-elevation myocardial infarction.
@en
A single dose of erythropoietin in ST-elevation myocardial infarction.
@nl
P2093
P2860
P356
P1476
A single dose of erythropoietin in ST-elevation myocardial infarction.
@en
P2093
Adriaan A Voors
Anne M S Belonje
Arnoud van 't Hof
Felix Zijlstra
HEBE III Investigators
Hans L Hillege
Hans Otto J Peels
J Wouter Jukema
Jeroen Vos
José P S Henriques
P2860
P304
P356
10.1093/EURHEARTJ/EHQ304
P577
2010-08-29T00:00:00Z